Key result
Acacetin treatment significantly improved left ventricular ejection fraction from 33.5% to 43.7% and reduced arrhythmia scores in rats following myocardial ischemia/reperfusion injury.
Why the study?
This study was conducted to determine the protective effect and mechanism of acacetin, a natural flavonoid with anti-inflammatory and antioxidant properties, on myocardial ischaemia/reperfusion injury.
Does acacetin improve myocardial ischemia/reperfusion injury in a rat model?
Does acacetin improve myocardial ischemia/reperfusion injury in a rat model?
Acacetin demonstrates cardioprotective effects against ischemia/reperfusion injury in rats by inhibiting oxidative stress and apoptosis via the Nrf-2/HO-1 pathway.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for acacetin in ischemia/reperfusion injury; should not change clinical practice pending human trials.
CONTEXT: Acacetin is a natural source of flavonoids with anti-inflammatory and antioxidant effects. OBJECTIVE: This study determines acacetin's protective effect and mechanism on myocardial ischaemia/reperfusion (I/R) injury. MATERIALS AND METHODS: Sprague-Dawley rats were divided into sham and I/R injury and treatment with acacetin. Acacetin (10 mg/kg) was subcutaneously injected for 7 days. ECG and echocardiography were conducted to determine arrhythmia and heart function. The pathological characters of the heart were determined with triphenyl tetrazolium chloride staining, Haematoxylin & Eosin staining, and Masson staining. Expression of proteins in infarct tissues was examined with western blots. RESULTS: Administrated with acacetin in I/R rats significantly reduced the arrhythmia score from 4.90 to 2.50 and the reperfusion arrhythmia score from 3.79 to 1.82 in the vehicle or the acacetin group, respectively. LVEF was improved from 33.5% in the I/R group to 43.7% in the acacetin group, LVFS was increased from 16.4% to 24.5%, LVIDs was decreased from 6.5 to 5.3 mm. The inflammatory cell infiltration, myocardial fibrosis, and collagen 1 and 3 were reduced by acacetin. Acacetin promoted SOD and decreased MDA. In myocardial tissues, the expression level of TLR4 and IL-6 were restrained, and IL-10 was promoted. Apoptotic protein Bax was suppressed, and anti-apoptotic protein Bcl-2 was promoted in the acacetin group. Interestingly, the transcription factor Nrf-2/HO-1 pathway was also reversed by acacetin. DISCUSSION AND CONCLUSION: Our findings indicated that acacetin has a potential therapeutic effect in clinical application on treating I/R-induced heart injury.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2022) studied Myocardial ischaemia/reperfusion (I/R) injury (n=36). Acacetin vs. Vehicle (saline) was evaluated on Left ventricular ejection fraction (LVEF) (p=<0.05). Acacetin treatment significantly improved left ventricular ejection fraction from 33.5% to 43.7% and reduced arrhythmia scores in rats following myocardial ischemia/reperfusion injury.
Synapse has enriched 10 related papers. Consider them for comparative context: